PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 1:50 AM ET

Sponsor Check › Person

Yakov Kogan

Related person on Form D filings · address state as listed: NY · listed Apr 3, 2009 → Dec 23, 2015

2issuers
6Form D filings
2009–2015years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:57 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:57 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

No SEC search has run yet for this person.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:57 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

1 of 5 offerings reports sales commissions totalling $30,000; 2 report finder's fees totalling $1,035,000; 0 report proceeds to related persons.

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Dec 23, 2015 D
File 021-253747
$0$0$0None listed on this filing
EDGAR ↗Dec 23, 2015 D
File 021-253748
$0$0$0None listed on this filing
EDGAR ↗Jul 16, 2015 D
File 021-243916
$0$685,000$0Ladenburg & Thalmann & Co., Inc. BrokerCheck CRD 505 ↗
EDGAR ↗Jul 3, 2014 D
File 021-220318
$30,000$0$0H.C.WAINWRIGHT & CO., LLC BrokerCheck CRD 375 ↗
EDGAR ↗Mar 5, 2010 D
File 021-74314
$0$350,000$0Rodman & Renshaw, LLC BrokerCheck CRD 16415 ↗
via Rodman & Renshaw, LLC (CRD 16415 ↗)

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗PANACELA LABS, INC.Executive OfficerDec 23, 2015D$2,902,600
similar: $2,000,000–$19,999,994
$2,902,6002
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Statera Biopharma, Inc.Executive Officer, DirectorDec 23, 2015D$1,140,157
similar: $2,000,000–$19,999,994
$1,140,1571
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Statera Biopharma, Inc.Executive Officer, DirectorJul 16, 2015D$25,000,000
similar: $2,000,000–$19,999,994
$25,000,0001
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Statera Biopharma, Inc.DirectorJul 3, 2014D$3,500,000
similar: $2,000,000–$19,999,994
$3,500,0003
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Statera Biopharma, Inc.Director, Executive OfficerMar 5, 2010D$5,000,000$5,000,0009No minimum reported
EDGAR ↗Statera Biopharma, Inc.Executive Officer, DirectorApr 3, 2009D$3,726,557$3,726,55743No minimum reported

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other listings under the same name

Separate person records under the same name, not combined with this page. Each line says whether it is listed on an issuer this record is also listed on (a second identifier); where it is not, it could be the same person or a different one.

  • Yakov Kogan — address state UT, 1 issuer, Oct 30, 2024 → Oct 30, 2024 · no shared issuer found

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 28 names on the same filings (0 management entities, 28 people)

People and management entities the issuers listed as related persons on the same Form D filings as Yakov Kogan. Source: the EDGAR rows in the table above.

  • Andrei Gudkov — 6 shared filings (2 issuers) · roles as listed: Executive Officer, Director
  • James Antal — 5 shared filings (1 issuer) · role as listed: Director
  • Randy S. Saluck — 3 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Anthony J. Principi — 3 shared filings (1 issuer) · role as listed: Director
  • C. Neil Lyons — 3 shared filings (1 issuer) · role as listed: Executive Officer
  • Richard S. McGowan — 3 shared filings (1 issuer) · role as listed: Director
  • Michael Fonstein — 2 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 2 other issuers
  • Daniel Perez — 2 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Paul DiCorleto — 2 shared filings (1 issuer) · role as listed: Director
  • Natalia Khudyk — 2 shared filings (1 issuer) · role as listed: Director
  • Natalia Saraeva — 2 shared filings (1 issuer) · role as listed: Director
  • Yulia Lebedina — 2 shared filings (1 issuer) · role as listed: Director
  • Anna Evdokimova — 2 shared filings (1 issuer) · role as listed: Director
  • Tatiana Levina — 2 shared filings (1 issuer) · role as listed: Director
  • Ivan Persiyanov — 2 shared filings (1 issuer) · role as listed: Director
  • Bernard L. Kasten — 2 shared filings (1 issuer) · role as listed: Director
  • John Allen Marhofer — 1 shared filing (1 issuer) · role as listed: Executive Officer · also listed on 2 other issuers
  • Jack Marhofer — 1 shared filing (1 issuer) · role as listed: Executive Officer
  • Daniel F. Hoth — 1 shared filing (1 issuer) · role as listed: Director
  • Julia R. Brown — 1 shared filing (1 issuer) · role as listed: Director
  • Alexander Polinsky — 1 shared filing (1 issuer) · role as listed: Director
  • Konstantinie Gorshkov — 1 shared filing (1 issuer) · role as listed: Director
  • Neil Lyons C — 1 shared filing (1 issuer) · roles as listed: Executive Officer, Director
  • Leysan Shaydullina — 1 shared filing (1 issuer) · role as listed: Director
  • Leah Brownlee — 1 shared filing (1 issuer) · roles as listed: Executive Officer, Director
  • Konstantin Gorshkov — 1 shared filing (1 issuer) · role as listed: Director
  • Langdon Miller, MD — 1 shared filing (1 issuer) · role as listed: Executive Officer
  • Dmitry Lisenkov — 1 shared filing (1 issuer) · role as listed: Director

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Yakov Kogan appears on a new Form D, or when a court case or SEC action is matched to them. See plans →